PI
ABMD

PGGM Investments’s Abiomed Inc ABMD Stock Holding History

PGGM Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.51M Hold
9,774
– – 0.02% 316
2021
Q4 		$3.51M Sell
9,774
-3,194
-25% -$1.08M 0.02% 316
2021
Q3 		$4.22M Sell
12,968
-21,822
-63% -$7.39M 0.02% 317
2021
Q2 		$10.9M Sell
34,790
-2,550
-7% -$782K 0.05% 263
2021
Q1 		$11.9M Buy
37,340
+10,386
+39% +$3.32M 0.05% 262
2020
Q4 		$8.74M Buy
+26,954
New +$7.46M 0.04% 281

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PGGM Investments's ABMD Position: Q1 2022 in Review

PGGM Investments held its Abiomed Inc (ABMD) position steady in Q1 2022 at 9,774 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #316.

PGGM Investments first reported a position in ABMD in Q4 2020 and has held it in 6 quarters since. The position peaked at $11.9M in Q1 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • PGGM Investments held 9,774 shares of Abiomed Inc worth $3.51M as of Q1 2022.
  • PGGM Investments left its Abiomed Inc share count unchanged in Q1 2022.
  • Abiomed Inc made up 0.02% of PGGM Investments's portfolio in Q1 2022, its #316 holding.
  • PGGM Investments first reported a position in Abiomed Inc in Q4 2020 and has held it in 6 quarters since.
  • PGGM Investments's Abiomed Inc position peaked at $11.9M in Q1 2021.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on PGGM Investments's 13F filing for Q1 2022, filed 25 Apr 2022.